Study Notes for BS2013: Physiology and Pharmacology

BS2013: Physiology and Pharmacology

Topic Overview

  • Topic 3: Applied Pharmacology
      - Part 1: General Principles
      - Part 2: Kinetic Models

Recommended Resources

  • TEXTBOOK:
      - Chapters: 9-11 of Rang and Dale’s Pharmacology (9th Edition)
      - Access: Available on the University Catalogue through the Blackboard site: Readings & Sources > Module Reading List > Reading for Pharmacokinetics Lectures

Introduction to Pharmacokinetics

  • Effectiveness of Drugs:
      - Pharmacokinetics refers to how drugs are processed in the body, covering the following key stages:
        - Absorption
        - Distribution
        - Metabolism
        - Excretion
      - These factors determine the concentration and time-course of drug distribution in the body, influencing optimal dosage and dosing regimens.
      - Drug-Receptor Interactions:
        - At the molecular level, these interactions relate to concepts such as potency and efficacy.

Drug Absorption

  • General Mechanism:
      - Drugs, in most cases, travel to tissues via the plasma.

  • Routes of Administration:
      1. Oral & Swallowed:
         - Common for small molecule drugs; may be subject to degradation in the GI tract.
      2. Sublingual:
         - Rapid absorption from the oral cavity (e.g., Glyceryl Trinitrate for vasodilation).
      3. Rectal:
         - Provides local or systemic effects when oral intake is not possible (e.g., nausea/vomiting).
      4. Epithelial Surfaces:
         - Includes skin, cornea, and nasal mucosa.
      5. Inhalation:
         - Utilized for gaseous anaesthetics and bronchodilators.
      6. Injection:
         - Most direct route, with forms including intravenous (fastest), subcutaneous, intramuscular, and intrathecal (lumbar puncture).

  • Factors Affecting Absorption:
      1. Site/Method of Administration
      2. Molecular Weight:
         - Major determinant of the rate of diffusion.
      3. Lipid Solubility:
         - Critical for crossing lipid membranes by diffusion.
      4. pH and Ionization:
         - Many drugs are weak acids or bases.
         - Example: Weak acid HA ⇌ H⁺ + A⁻ with the equation
    extpKa=extpH+extlog10[extAH][extA]ext{pKa} = ext{pH} + ext{log}_{10}\frac{[ ext{AH}]}{[ ext{A}^-]}
         - Note that at low pH, weak acids remain mostly un-ionized, allowing diffusion across lipid bilayers (e.g., stomach pH 1.5-2).
      5. Carrier Mediated Transport:
         - Active or facilitated transport for polar molecules such as amino acids and metal ions.
         - Example: Gases, with diffusivity (D \propto \frac{1}{\sqrt{\text{MWt}}}).

Drug Distribution

  • Major Body Compartments:
      1. Extracellular Fluids:
         - Plasma: 4.5% body weight
         - Interstitial Fluid: 16%
         - Lymph: 1-2%
      2. Intracellular Fluids:
         - 30-40%
      3. Transcellular Fluids:
         - Examples include cerebrospinal fluid (CSF) and intraocular fluid, constituting 2.5%.
      4. Fat:
         - Accounts for 20%, influencing drug distribution based on lipid solubility and permeability.

  • Blood-Brain Barrier:
      - Comprised of endothelial cells forming tight junctions, which create a barrier to systemically acting drugs (typically those >400-500 daltons).
      - Drugs must cross cell membranes and tight junctions may become leaky during inflammation.
      - Example Experiment: Paul Ehrlich's Injection of water-soluble dye (trypan blue), which stained all organs except the brain; conversely, injecting it into the brain stained it but not the rest of the body.

Drug Metabolism

  • Definition:
      - Refers to the enzymatic modification of drugs prior to excretion, usually rendering the drugs pharmacologically inactive, though exceptions exist (e.g., thienopyridines serve as prodrugs for P2Y12 inhibition).

  • Phases of Metabolism:
      1. Phase 1
         - Involves oxidation, reduction, or hydrolysis via the Cytochrome P450 (CYP) monooxygenase system, primarily located in the smooth endoplasmic reticulum of the liver.
         - Notable CYP enzymes (e.g., CYP1A2 metabolizes caffeine and paracetamol).
         - Other systems include alcohol dehydrogenase (cytoplasmic).
      2. Phase 2
         - Involves conjugation, the addition of substituent groups (e.g., methyl, sulfate, acetyl) that generally inactivate substances.
         - Both phases decrease lipid solubility, therefore enhancing kidney clearance.

Drug Excretion

  • General Mechanism:
      - Drugs are eliminated from the body primarily through renal mechanisms but also via gastrointestinal and pulmonary pathways.

  • Renal Excretion:
      - Four basic processes:
        1. Glomerular Filtration (GF):
           - Non-discriminant filtration of protein-free plasma into Bowman’s capsule, approximately 20% of glomerular blood flow with a cut-off near 20 kDa, with 99% of water reabsorbed.
        2. Tubular Reabsorption (TR):
           - Selective movement from the tubular lumen into peritubular capillaries.
        3. Tubular Secretion (TS):
           - Selective movement of non-filtered substances from peritubular capillaries into tubular lumen.
        4. Urine Excretion (UE):
           - Creation of the medullary vertical osmotic gradient.
        - Characteristics of Renal Excretion:
           - Active tubular secretion is crucial for weak acids and plasma protein-bound drugs, with poor reabsorption for poorly lipid-soluble compounds.
           - Renal disease may impair drug clearance and result in toxicity.

  • Gastrointestinal (GI) Excretion:
      - Biliary excretion from the liver; relevant for certain drugs.

  • Lung Excretion:
      - Expulsion of volatile or gaseous agents; example includes rapid clearance of penicillin versus the slower clearance of diazepam, which is contingent on urine pH affecting weak acid/base excretion.

Kinetic Models in Pharmacokinetics

  • Purpose of Kinetic Models:
      - To predict the time-course of drug action, integrating absorption, distribution, metabolism, and elimination.
One-Compartment Model
  • Concept:
      - Represents the body as a single well-stirred compartment where drug elimination is proportional to plasma drug concentration.
  • Key Variables:
      - (K_A): Rate of drug absorption
      - (V_d): Volume of drug distribution
      - (C_P): Concentration of drug in the compartment
      - (K_{El}): Rate of elimination (excretion + metabolism), also referred to as clearance.
  • Single Drug Infusion:
      - The decay of the drug concentration follows an exponential time-course characterized by the half-life (T½), which indicates the time taken for the concentration to reduce by 50%.
      - For an intravenous bolus, drug concentration spiking occurs instantly, later declining exponentially.
Two-Compartment Model
  • Concept:
      - More complex, applicable to many drugs where drug disappearance does not follow a single exponential decay.
      - Characterized by a central compartment (plasma) and a peripheral compartment (tissues).
  • Key Rate Constants in Two-Compartment Model:
      - (K_{Pl:Tiss}): Rate of transfer from plasma to tissues, typically greater than (K_{El}).
  • Decay Phases:
      - Slow decay estimates the elimination rate constant.

Summary Points on Pharmacokinetics

  • Drug Administration Routes:
      - Approximately six routes exist, including inhalation and injection.
  • Chemical Properties:
      - Properties such as lipid solubility govern drug distribution across body compartments due to their effects on absorption, distribution, metabolism, and excretion.
  • Blood-Brain Barrier:
      - Access to the brain compartment is tightly regulated due to the properties of the blood-brain barrier.
  • One-Compartment Model:
      - Models the kinetics of drug concentration with single exponential decay, while more complex models are often required to accurately depict multi-compartmental behavior.

Sample Single Best Answer Questions (SBAQ)

  1. SBAQ 1:
       - Question: A patient is taking drug K once a day to achieve the optimal average plasma concentration required to treat their medical condition. After starting an additional drug F that promotes kidney excretion of drug K, what could result from taking both drugs compared to just drug K?
       - Options:
         - A. No change in the average concentration of drug K in the plasma
         - B. Need to increase frequency of administration of drug K to achieve same average effective concentration in plasma
         - C. Increase in average concentration of drug K in the plasma
         - D. Increase in the half-life of drug K in the plasma

  2. SBAQ 2:
       - Question: If the half-life of a drug in the body is 2 hours, how long would it take for the concentration of the drug to drop from 4 µg/ml to 125 ng/ml?
       - Options:
         - A. 5 hours
         - B. 8 hours
         - C. 10 hours
         - D. 16 hours
       - Calculation Path:
         - Initial concentration: 4 µg/ml = 4000 ng/ml.
         - Steps: 4000 → 2000 → 1000 → 500 → 250 → 125 = 5 half-lives = 10 hours.